Sanofi’s new CEO laid out plans Tuesday to shake up one of the Bay State’s biggest drug companies, potentially throwing its 3-year-old diabetes-focused startup...
Fake shopping sprees and ‘happiness insurance’: The latest fintech apps reveal our financial anxieties






